<DOC>
	<DOCNO>NCT02094365</DOCNO>
	<brief_summary>This study design compare antiviral effect ALS-008176 compare placebo control respiratory syncytial virus challenge model .</brief_summary>
	<brief_title>A Phase 2a Study Evaluate ALS-008176 Virus Challenge Model</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Respiratory Syncytial Virus Infections</mesh_term>
	<criteria>Age 18 45 year , inclusive . In good health history major medical condition A total body weight â‰¥ 50 kg body mass index ( BMI ) &gt; 18kg/m2 . Acute chronic medical illness Positive Human Immunodeficiency Virus , Hepatitis B C Nose nasopharynx abnormality Abnormal lung function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>